Italia markets closed

SIGA Jun 2024 6.900 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,6500-0,0900 (-12,16%)
In data: 09:56AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,7400
Aperto0,6500
Denaro0,7000
Domanda0,8000
Prezzo d'esercizio6,90
Scadenza2024-06-21
Min-Max giorno0,6500 - 0,6500
Contratto - Min-MaxN/D
Volume20
Open Interest1,76k
  • GlobeNewswire

    SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

    NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO). He will also continue to serve as a director of the SIGA Board of Directors. “As SIGA has worked to support the global response to the MPOX outbreak and as we continue to expand our role in planning for the preve

  • GlobeNewswire

    SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023

    - In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2023. “SIGA’s second quarter financial results reflect the continuation of international sales activity that

  • GlobeNewswire

    SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®

    Exercise of Procurement Options of Approximately $113 Million for Oral TPOXX and Approximately $25 Million for IV TPOXX under Current Contract reflects continuing global action to enhance smallpox preparednessNEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised procurement options for the delivery of approximately $113 million worth of o